Hepatology

Aims & Scope

The premier publication in the field of liver disease publishes original, peer-reviewed articles concerning all aspects of liver structure, function and disease.

Each month, the distinguished editorial board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	15.8
2024	12.90

Journal Citation Indicator

Year	Value
2024	14591

SJR (SCImago Journal Rank)

Year	Value
2024	5.557

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	415

Journal Rank

Year	Value
2024	243

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

  Citation: 8860

  Authors: David E., Elizabeth M., Mark, Cynthia, Melissa J., Oscar W., Linda D., Yao‐Chang, Michael S., Aynur, Matthew, Arthur J., Arun J.

• Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes

  Citation: 8605

  Authors: Zobair M., Aaron B., Dinan, Yousef, Linda, Mark

• Management of Hepatocellular Carcinoma: An Update Δσ

  Citation: 6567

  Authors: Jordi, Morris

• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

  Citation: 5610

  Authors: Naga, Zobair, Joel E., Michael, Kenneth, Mary, Stephen A., Elizabeth M., Arun J.

• Management of Hepatocellular Carcinoma *

  Citation: 4571

  Authors: Jordi, Morris

• A Model to Predict Survival in Patients With End–Stage Liver Disease

  Citation: 4073

  Authors: Patrick S., Russell H., Michael, Walter, Terry M., Catherine L., Gennaro, Rolland E., Ray W.

• Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

  Citation: 3871

  Authors: Richard K., Eduardo, Nathan, Ricard, Mendes Cassia, Julio, Mark, Francesca J., Doug T., David L., Diethelm, Mark

• Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

  Citation: 3648

  Authors: Jorge A., Laura M., Claude B., Andrew X., Richard S., Michael M., Lewis R., Julie K.

• A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C

  Citation: 3377

  Authors: Chun-Tao, Joel K., Robert J., John D., Jorge A., Hari S., Anna S.-F.

• Update on prevention, diagnosis, and treatment of chronic hepatitis B

  Citation: 3306

  Authors: Norah A., Anna S.F., Brian J., Kyong‐Mi, Jessica P., Maureen M., Robert S., Natalie H., John B.

---